X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Glioblastoma Multiforme Treatment Companies

This report lists the top Glioblastoma Multiforme Treatment companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Glioblastoma Multiforme Treatment industry.

Glioblastoma Multiforme Treatment Top Companies

  1. Arbor Pharmaceuticals, LLC

  2. F. Hoffmann-La Roche Ltd

  3. Merck & Co. Inc.

  4. Sun Pharmaceutical Industries Ltd.

  5. Teva Pharmaceutical Industries Ltd.

*Disclaimer: Top companies sorted in no particular order

 Glioblastoma Multiforme Treatment Market Major Players

Glioblastoma Multiforme Treatment Market Concentration

Glioblastoma Multiforme Treatment Market Concentration

Glioblastoma Multiforme Treatment Company List

                            • Arbor Pharmaceuticals, LLC

                            • Bristol-Myers Squibb Company

                            • Eli Lilly and Company

                            • F. Hoffmann-La Roche Ltd

                            • Merck & Co. Inc.

                            • Sun Pharmaceutical Industries Ltd.

                            • Lanthen Pharmaceutical

                            • Pfizer Inc.

                            • Amgen Inc.

                            • Teva Pharmaceutical Industries Ltd.


                        Specific to Glioblastoma Multiforme Treatment Market
                        Need More Details On Market Players And Competitors?
                        Download Sample

                        Glioma Diagnosis and Treatment Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)